Evidence map›Paper›PMID 34553093›Full record

ArticleCurrent medical mycology2021

Epidemiological profile and antifungal susceptibility pattern of

Vibha Mehta, Jagdish Chander, Neelam Gulati, Nidhi Singla, Hena Vasdeva, Raman Sardana, Awadhesh Kumar Pandey

Open access · diamondAbstract read
In one paragraph

Article in Current medical mycology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Future microbiology · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vibha MehtaDepartment of Microbiology, Government Medical College Hospital, Chandigarh, India.
Jagdish ChanderDepartment of Microbiology, Government Medical College Hospital, Chandigarh, India.
Neelam GulatiDepartment of Microbiology, Government Medical College Hospital, Chandigarh, India.
Nidhi SinglaDepartment of Microbiology, Government Medical College Hospital, Chandigarh, India.
Hena VasdevaDepartment of Microbiology, Indraprastha Apollo Hospitals, New Delhi, India.
Raman SardanaDepartment of Microbiology, Indraprastha Apollo Hospitals, New Delhi, India.
Awadhesh Kumar PandeyDepartment of Radiotherapy, Government Medical College Hospital, Chandigarh, India.
Government Medical College · INIndraprastha Apollo Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMATERIALS AND

methodsIn total, 50 clinical isolates of

resultsIntravenous catheters, antibiotics, and antifungal uptake were significantly associated risk factors with

conclusionTrichosporonosis is being increasingly reported all around the world, including India. The results of this study highlighted the importance of early detection and treatment for this emerging yeast and also added to the ongoing surveillance for the antifungal susuceptibility pattern for this fungus.

Indexed as

Antifungal susceptibilityInvasive trichosporonosisMinimum inhibitory concentrationTrichosporonVoriconazole

Identifiers

PMID34553093
PMCPMC8443878
OpenAlexW3137407873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.